首页> 外文会议>General Meeting of European Society of Animal Cell Technology >T-Lymphocytes Transduced with SFCMM-3 Vector in a Closed System
【24h】

T-Lymphocytes Transduced with SFCMM-3 Vector in a Closed System

机译:在封闭系统中用SFCMM-3载体转导的T淋巴细胞

获取原文
获取外文期刊封面目录资料

摘要

Safety, yield and scalability represent critical issues in production of gene-modified cells (GMC) for clinical applications. Currently open systems, based on culture flasks, are used for production of TK-transduced T cells. Such systems may be used,without significant risk of contamination, only if limited numbers of cells (up to 108-109) are required. Thus a method for cell manipulation and culturing in a closed system has been developed. Lymphocytes are cultured in bags, activated with OKT3, thentransduced with the vector SFCMM-3, carrying the HSV-TK and ALNGFR genes. After a few days, lymphocytes are collected and the percentage of transduced cells is evaluated by FACS analysis. Transduced cells are sorted by antibody conjugated magnetic beadsand then expanded in culture. The full process lasts 10 days. The following instruments are used: CytoMateTM Cell Processing System (Nexell Therapeutic Inc.), for cell thawing, washing and harvest, and IsolexTM 300 Magnetic Cell Separation System (Baxter), for selection of the transduced cells. The closed-system is very efficient and the cell yield is higher than that obtained in the open-system (final cell number/initial cell number: 0.64 versus 0.39). A detailed analysis of the process indicates thatthe steps in which the closed system shows major advantages are transduction (23% versus 17%) and selection (recovery of the cells 67% versus 36%). The purity of the final product is very similar and shows the homogeneity of the final population of GMC(94% and 95% LNGFR positive cells, respectively). Only the proliferation rate is lower in the closed than in the open system, especially post-transduction (2.5 versus 4.7) and post-selection (3.6 versus 5.6). However, the development of cell culturing using different bags or different culture media could improve cell growth. These results demonstrate the feasibility of a method for transduction and selection of GMC in a closed system that is safe and efficient.
机译:安全性,产量和可扩展性代表临床应用生产基因改性细胞(GMC)的关键问题。目前基于培养烧瓶的开放系统用于生产TK转导的T细胞。可以使用这种系统,而无需污染的风险,只有需要有限数量的细胞(最高108-109)。因此,已经开发了一种用于细胞操纵和在封闭系统中培养的方法。淋巴细胞在袋中培养,用OKT3活化,用载体SFCMM-3进行,携带HSV-TK和ALNGFR基因。几天后,收集淋巴细胞,通过FACS分析评估转导细胞的百分比。通过抗体缀合的磁珠和在培养物中膨胀,转导细胞。完整的过程持续10天。使用以下仪器:细胞瘤细胞加工系统(Nexell治疗型Inc.),用于细胞解冻,洗涤和收获,以及ISOLextm 300磁性电池分离系统(Baxter),用于选择转导电池。闭合系统非常高效,电池产量高于开放系统中获得的电池产量(最终细胞数/初始单元数:0.64与0.39)。对该过程的详细分析表明,封闭系统显示主要优势的步骤是转导(23%对17%)和选择(细胞的回收率为67%,而36%)。最终产品的纯度非常相似,并显示出GMC最终群体的均匀性(94%和95%LNGFR阳性细胞)。关闭的增殖率低于开放系统,尤其是转导后(2.5与4.7)和选择后(3.6与5.6)。然而,使用不同袋或不同培养基培养的细胞的发展可以改善细胞生长。这些结果表明,在封闭系统中转导和选择GMC的方法的可行性,这是安全和有效的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号